Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 13.44
(0.0%)
CNY 13.44
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.13 Billion CNY | -20.84% |
| 2022 | 5.02 Billion CNY | 5.61% |
| 2021 | 4.75 Billion CNY | 13.87% |
| 2020 | 4.17 Billion CNY | 37.74% |
| 2019 | 3.03 Billion CNY | 21.39% |
| 2018 | 2.49 Billion CNY | 16.57% |
| 2017 | 2.14 Billion CNY | 12.61% |
| 2016 | 1.9 Billion CNY | 23.49% |
| 2015 | 1.54 Billion CNY | 5.44% |
| 2014 | 1.46 Billion CNY | 2.63% |
| 2013 | 1.42 Billion CNY | 46.06% |
| 2012 | 975.48 Million CNY | 15.21% |
| 2011 | 846.67 Million CNY | 13.27% |
| 2010 | 747.46 Million CNY | 14.9% |
| 2009 | 650.54 Million CNY | 60.78% |
| 2008 | 404.6 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 908.87 Million CNY | 12.95% |
| 2024 Q1 | 891.44 Million CNY | -12.56% |
| 2024 Q2 | 804.99 Million CNY | -9.7% |
| 2023 Q3 | 849.85 Million CNY | -27.22% |
| 2023 Q4 | 1.01 Billion CNY | 19.96% |
| 2023 Q1 | 1.09 Billion CNY | -41.69% |
| 2023 Q2 | 1.16 Billion CNY | 6.94% |
| 2023 FY | 3.97 Billion CNY | -20.84% |
| 2022 Q3 | 1.01 Billion CNY | -5.55% |
| 2022 Q2 | 1.07 Billion CNY | 0.42% |
| 2022 Q1 | 1.06 Billion CNY | 3.61% |
| 2022 Q4 | 1.87 Billion CNY | 84.88% |
| 2022 FY | 5.02 Billion CNY | 5.61% |
| 2021 FY | 4.75 Billion CNY | 13.87% |
| 2021 Q1 | 1.53 Billion CNY | 13.18% |
| 2021 Q2 | 1.12 Billion CNY | -26.42% |
| 2021 Q3 | 1.06 Billion CNY | -5.13% |
| 2021 Q4 | 1.03 Billion CNY | -3.61% |
| 2020 Q3 | 873.39 Million CNY | -9.07% |
| 2020 Q4 | 1.35 Billion CNY | 54.95% |
| 2020 FY | 4.17 Billion CNY | 37.74% |
| 2020 Q1 | 991.95 Million CNY | 22.88% |
| 2020 Q2 | 960.49 Million CNY | -3.17% |
| 2019 Q3 | 742.05 Million CNY | -9.65% |
| 2019 Q1 | 663.37 Million CNY | 10.01% |
| 2019 Q2 | 821.34 Million CNY | 23.81% |
| 2019 Q4 | 807.24 Million CNY | 8.78% |
| 2019 FY | 3.03 Billion CNY | 21.39% |
| 2018 Q3 | 609.56 Million CNY | 10.02% |
| 2018 FY | 2.49 Billion CNY | 16.57% |
| 2018 Q1 | 732.89 Million CNY | 27.44% |
| 2018 Q2 | 554.02 Million CNY | -24.41% |
| 2018 Q4 | 602.99 Million CNY | -1.08% |
| 2017 Q1 | 635.84 Million CNY | 33.7% |
| 2017 Q3 | 440.2 Million CNY | -10.71% |
| 2017 FY | 2.14 Billion CNY | 12.61% |
| 2017 Q4 | 575.09 Million CNY | 30.64% |
| 2017 Q2 | 492.99 Million CNY | -22.47% |
| 2016 FY | 1.9 Billion CNY | 23.49% |
| 2016 Q1 | 528.71 Million CNY | 41.31% |
| 2016 Q2 | 486.37 Million CNY | -8.01% |
| 2016 Q3 | 413.35 Million CNY | -15.01% |
| 2016 Q4 | 475.56 Million CNY | 15.05% |
| 2015 Q1 | 396.55 Million CNY | 13.63% |
| 2015 Q4 | 374.16 Million CNY | 2.11% |
| 2015 Q3 | 366.44 Million CNY | -9.46% |
| 2015 Q2 | 404.71 Million CNY | 2.06% |
| 2015 FY | 1.54 Billion CNY | 5.44% |
| 2014 Q4 | 348.97 Million CNY | 3.25% |
| 2014 FY | 1.46 Billion CNY | 2.63% |
| 2014 Q2 | 365.33 Million CNY | -10.9% |
| 2014 Q1 | 410.01 Million CNY | -4.88% |
| 2014 Q3 | 337.99 Million CNY | -7.48% |
| 2013 Q4 | 431.06 Million CNY | 21.32% |
| 2013 FY | 1.42 Billion CNY | 46.06% |
| 2013 Q1 | 332.77 Million CNY | -16.59% |
| 2013 Q2 | 305.63 Million CNY | -8.15% |
| 2013 Q3 | 355.31 Million CNY | 16.25% |
| 2012 FY | 975.48 Million CNY | 15.21% |
| 2012 Q1 | 206.4 Million CNY | -20.98% |
| 2012 Q2 | 121.72 Million CNY | -41.03% |
| 2012 Q3 | 248.37 Million CNY | 104.04% |
| 2012 Q4 | 398.97 Million CNY | 60.64% |
| 2011 Q1 | 179.98 Million CNY | -34.48% |
| 2011 Q2 | 197.67 Million CNY | 9.83% |
| 2011 Q3 | 207.78 Million CNY | 5.12% |
| 2011 Q4 | 261.22 Million CNY | 25.72% |
| 2011 FY | 846.67 Million CNY | 13.27% |
| 2010 Q3 | 159.51 Million CNY | 0.0% |
| 2010 Q4 | 274.7 Million CNY | 72.22% |
| 2010 FY | 747.46 Million CNY | 14.9% |
| 2009 FY | 650.54 Million CNY | 60.78% |
| 2008 FY | 404.6 Million CNY | 0.0% |